SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-145685
Filing Date
2024-05-23
Accepted
2024-05-23 12:12:31
Documents
13
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d835195d8k.htm   iXBRL 8-K 27565
  Complete submission text file 0001193125-24-145685.txt   150251

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA labp-20240523.xsd EX-101.SCH 2862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE labp-20240523_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE labp-20240523_pre.xml EX-101.PRE 11266
16 EXTRACTED XBRL INSTANCE DOCUMENT d835195d8k_htm.xml XML 3626
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39971 | Film No.: 24976399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)